CTE

Cryosite Limited

1 day chart

About CTE

Cryosite (CTE) is an Australian company which provides outsourced clinical trials logistic services. The company manages the entire clinical trial supply chain from importation, receipt, specialised ambient, cold, frozen, and liquid nitrogen storage for temperature sensitive products, distribution, and reverse logistics management.

Buy Australian shares starting with CTE. Invest today with a CHESS-sponsored investing platform!

Sector

Health Care

CEO

Mr John Hogg

Industry

Life Sciences Tools & Services

Website

cryosite.com

Market Capitalisation

$27M

Price-earnings ratio

19.03

Dividend yield

2.31%

High today

$0.55

Low today

$0.55

Open price

$0.55

52-week high

$0.84

52-week low

$0.51

Announcements

CTE FAQs

Can I buy CTE shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake platform allows you to buy CTE shares and over 8,000 stocks and ETFs across the ASX and Wall St.

How much is one share of Cryosite Limited?

One share of Cryosite Limited is valued at $0.55.

What is the ticker symbol for Cryosite Limited?

The ticker symbol for Cryosite Limited is CTE.

How do I buy CTE shares in Australia?

To buy CTE stocks in Australia you'll need to open an account with an investing platform like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake AUS
Deposit directly into your Stake wallet and you're ready to invest in CTE

What is the 52-week high for Cryosite Limited stock?

The Cryosite Limited 52-week high stock price is $0.84.

What is the 52-week low for Cryosite Limited stock?

The Cryosite Limited 52-week low stock price is $0.51.

What is the market capitalisation of Cryosite Limited CTE?

As of 06/12/2023 Cryosite Limited has a market cap of $27M.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.